JAMP LENALIDOMIDE

Identification of Jamp Lenalidomide

No description

Google image searchProduct monograph

Active ingredient

lenalidomide, 15 MG

DIN: 02506165

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: JAMP PHARMA CORPORATION

Date: 02-FEB-2022

ATC:

Reference brand drug: Revlimid

Pharmaceutical standard: MFR

Search on Google